Latest Uganda News

Blaze Minerals reported a narrower FY2026 loss, but ended the year with just $43,552 in cash and an auditor-highlighted material uncertainty over its ability to continue as a going concern. The company is relying on shareholder-approved funding, a proposed 20:1 consolidation and a conditional Ugandan tungsten acquisition to reshape its next phase.

eMetals has shifted its exploration focus from Uganda to a larger Utah tungsten project, where high-grade re-assays have set up a 17-hole drilling campaign. But the ASX-listed explorer ended the year with $1.79 million in cash, $1.40 million of deferred consideration and an auditor-highlighted material uncertainty over its ability to continue as a going concern.

Ionic Rare Earths is pushing toward commercial magnet recycling in Belfast and the United States, but its FY2026 report flags a material uncertainty over its ability to continue as a going concern. The company reported a larger A$14.9 million loss and A$13.9 million in operating cash outflows, despite government support and new strategic partnerships.

Blaze Minerals has struck a binding deal to acquire a majority interest in two historically rich tungsten projects in Uganda, backed by a $2.25 million capital raise to fund exploration and acquisition costs.

Island Pharmaceuticals has commissioned a second manufacturing run of its antiviral Galidesivir, aiming to stockpile up to 800 treatment courses by late 2026 to support rapid response to the fast-spreading Bundibugyo Ebola outbreak and biodefence efforts.

Ionic Rare Earths (ASX: IXR) has secured $8 million through a placement to back its Belfast Plant commercialisation and US growth plans, supported by a mix of domestic and international investors including a strategic US partner.

Island Pharmaceuticals has marked a major step forward in its antiviral program with the start of GMP manufacturing for Galidesivir, expanded USAMRIID collaboration, and FDA orphan drug designation. Regulatory approvals for compassionate use in Uganda’s Ebola outbreak and a new dose optimisation study with Texas Biomed further de-risk the pathway to approval.

Blaze Minerals has reported significant copper, lead, and zinc mineralisation at its Krokodil Prospect within Botswana’s Dinokwe Project, supported by trenching and rock-chip sampling results. The company is advancing exploration amid tight cash reserves, aiming for a capital raise to sustain operations.

eMetals Limited has significantly grown its Mineral Range Tungsten Project in Utah, securing all mineral claims and reporting multiple high-grade tungsten samples, while completing a 10:1 share consolidation.

Island Pharmaceuticals is progressing its broad-spectrum antiviral Galidesivir amid a severe Ebola outbreak, securing government approvals in Uganda and outlining a dual clinical and regulatory development pathway targeting multiple deadly filoviruses.

Blaze Minerals has completed a 443-metre trenching campaign at its Krokodil Prospect in Botswana, confirming in-situ copper, lead, and zinc mineralisation with notable spot XRF readings. Laboratory assay results are expected in 6-8 weeks as the company plans further soil sampling to extend the target zone.

Ionic Rare Earths (ASX: IXR) has secured binding agreements to supply critical rare earth oxides to US-based Advanced Magnet Lab, supporting domestic production of permanent magnets for defence applications under a US Defense Logistics Agency contract.